Drug intelligence / Profile preview

iothalamate

Development stage
Approved
Lead developer
Mallinckrodt
Modality
Small Molecules
Administration
Intravenous, Intra-arterial, Intravesical, Intratumoral, Subcutaneous
01

Overview

Iothalamate is an iodinated radiopaque contrast medium and diagnostic agent used primarily for medical imaging and the assessment of renal function. As a marker for glomerular filtration rate (GFR), it is considered a reference standard because it is filtered by the glomeruli without significant tubular secretion or reabsorption. It is available in non-radioactive formulations (e.g., Conray) for various diagnostic procedures, including excretory urography, angiography, and CT scan enhancement of the brain and abdominal organs. Additionally, radioisotopic versions such as iothalamate sodium I-125 (Glofil-125) are utilized for precise GFR measurement, while Iotrex (sodium iothalamate I-125) was developed as a liquid radiation source for the GliaSite radiation therapy system to treat brain cancer via internal brachytherapy.

Brand names
ConrayConray 43Conray43Conray-43Cysto-Conray IIGlofil-125Glofil125Glofil 125Iotrex
Other names
iothalamic acidiothalamate meglumineiothalamate sodiumsodium iothalamatemeglumine iothalamateradioisotopic iothalamate

Beyond the preview

Go deeper on iothalamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iothalamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call